The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-((4-amino-3-(1H-indol-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)piperidin-1-yl)ethanone ID: ALA4789563
PubChem CID: 162668674
Max Phase: Preclinical
Molecular Formula: C21H23N7O
Molecular Weight: 389.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N1CCC(Cn2nc(-c3c[nH]c4ccccc34)c3c(N)ncnc32)CC1
Standard InChI: InChI=1S/C21H23N7O/c1-13(29)27-8-6-14(7-9-27)11-28-21-18(20(22)24-12-25-21)19(26-28)16-10-23-17-5-3-2-4-15(16)17/h2-5,10,12,14,23H,6-9,11H2,1H3,(H2,22,24,25)
Standard InChI Key: HZNRBKQXNAXNTQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
28.8535 -27.8175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5511 -27.3882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7118 -24.9115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4773 -25.7009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0436 -26.2987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.5083 -24.7204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5256 -26.5688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1786 -26.0660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9009 -25.2894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0762 -25.3148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8468 -26.1071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7387 -23.9322 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2704 -24.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4798 -23.2441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8976 -23.8258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2078 -23.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0783 -24.4282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7135 -24.9405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4784 -24.6497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6044 -23.8376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9681 -23.3247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1330 -27.4258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4373 -27.8516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4561 -28.6708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1766 -29.0626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8783 -28.6350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7585 -29.0965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0411 -28.7052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7783 -29.9134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
4 5 1 0
5 11 2 0
10 6 2 0
6 3 1 0
10 11 1 0
8 9 2 0
7 8 1 0
9 10 1 0
11 7 1 0
6 12 1 0
7 2 1 0
9 13 1 0
13 17 1 0
16 14 1 0
14 15 1 0
15 13 2 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 1 1 0
1 22 1 0
1 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
24 27 1 0
27 28 1 0
27 29 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.46Molecular Weight (Monoisotopic): 389.1964AlogP: 2.82#Rotatable Bonds: 3Polar Surface Area: 105.72Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.73CX LogP: 1.48CX LogD: 1.48Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -0.92
References 1. Gilles P,Kashyap RS,Freitas MJ,Ceusters S,Van Asch K,Janssens A,De Jonghe S,Persoons L,Cobbaut M,Daelemans D,Van Lint J,Voet ARD,De Borggraeve WM. (2020) Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyrimidine-based protein kinase D inhibitors., 205 [PMID:32835918 ] [10.1016/j.ejmech.2020.112638 ]